3Q 2017 ASP drug price limits continue upward trend — mostly for high-end drugs

Why This Topic Matters

ASP updates can affect reimbursement, budgeting, and utilization patterns across provider settings. The article highlights how small percentage changes may matter for high-cost drugs and for widely used drugs with large claim volumes.

Article Sections

1. ASP price trend overview

   Summarizes the overall direction of CMS ASP drug price revisions across multiple time periods. It frames the article’s comparison of short-term and longer-term pricing movement.

2. Large quarterly and annual price changes

   Reviews the most notable increases and decreases in drug pricing over the quarter and over the prior year. This section emphasizes how changes vary across different drug categories and price points.

3. Small shifts, but big prices

   Discusses the impact of relatively small price changes on expensive therapies and on heavily utilized drugs. It also introduces a table of commonly billed drugs and their ASP movements.